Detalhe da pesquisa
1.
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution.
Anticancer Drugs
; 30(7): e0787, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31305295
2.
Differential Effects of Variations at Codon 106 on Sprouty2 Functions in Lung Cancer-Derived Cells.
J Cell Biochem
; 117(8): 1822-32, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26727965
3.
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Am J Respir Crit Care Med
; 190(7): 763-72, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25188816
4.
Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med
; 11(14)2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887862
5.
Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients.
Cancers (Basel)
; 14(9)2022 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565374
6.
Bronchoscopic diagnosis and treatment of endobronchial carcinoid: case report and review of the literature.
Eur Respir Rev
; 30(159)2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408086
7.
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.
Biomolecules
; 11(5)2021 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919291
8.
EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib.
Transl Lung Cancer Res
; 9(2): 239-245, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420063
9.
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
Pharmaceuticals (Basel)
; 13(11)2020 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171712
10.
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
Mol Cancer Ther
; 7(10): 3408-19, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18852144
11.
EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
Target Oncol
; 14(2): 197-203, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30810887
12.
Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Mol Cancer Res
; 5(5): 509-20, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17510316
13.
Pulmonary tumorlet: a case report of a diagnostic pitfall in cytology.
Acta Cytol
; 52(2): 223-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18500000
14.
Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Cancer Res
; 66(7): 3584-92, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16585183
15.
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
J Thorac Oncol
; 13(6): 821-830, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29505901
16.
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe.
J Mol Diagn
; 20(4): 483-494, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704571
17.
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
J Cancer Res Clin Oncol
; 131(6): 355-63, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15856298
18.
Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
Clin Lung Cancer
; 21(2): e49-e53, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879191
19.
Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformation.
Int J Oncol
; 44(4): 1325-34, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452750
20.
Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
Eur J Cardiothorac Surg
; 39(2): 180-4, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20580243